[PDF][PDF] The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia

U Klein, M Lia, M Crespo, R Siegel, Q Shen, T Mo… - Cancer cell, 2010 - cell.com
U Klein, M Lia, M Crespo, R Siegel, Q Shen, T Mo, A Ambesi-Impiombato, A Califano
Cancer cell, 2010cell.com
Chronic lymphocytic leukemia (CLL) is a malignancy of B cells of unknown etiology.
Deletions of the chromosomal region 13q14 are commonly associated with CLL, with
monoclonal B cell lymphocytosis (MBL), which occasionally precedes CLL, and with
aggressive lymphoma, suggesting that this region contains a tumor-suppressor gene. Here,
we demonstrate that deletion in mice of the 13q14-minimal deleted region (MDR), which
encodes the DLEU2/miR-15a/16-1 cluster, causes development of indolent B cell …
Summary
Chronic lymphocytic leukemia (CLL) is a malignancy of B cells of unknown etiology. Deletions of the chromosomal region 13q14 are commonly associated with CLL, with monoclonal B cell lymphocytosis (MBL), which occasionally precedes CLL, and with aggressive lymphoma, suggesting that this region contains a tumor-suppressor gene. Here, we demonstrate that deletion in mice of the 13q14-minimal deleted region (MDR), which encodes the DLEU2/miR-15a/16-1 cluster, causes development of indolent B cell-autonomous, clonal lymphoproliferative disorders, recapitulating the spectrum of CLL-associated phenotypes observed in humans. miR-15a/16-1-deletion accelerates the proliferation of both human and mouse B cells by modulating the expression of genes controlling cell-cycle progression. These results define the role of 13q14 deletions in the pathogenesis of CLL.
cell.com